| || |
| ||WSJ.com: Markets07:30 |
copyright © 2018 Dow Jones & Company, Inc.
| |1. Abbott Labs Is a Rare Growth Story in Health CareПн., 20 авг.[−]
|The reason to buy shares in Abbott Labs is simple:The company is growing its top line faster than just about any health-care company of comparable size and since it doesn’t sell pharmaceuticals in the U.S., it is relatively insulated from regulatory risk.||↑|